Latest Market Research Report 2025

  Lateral Flow Assays Industry Overview The global lateral flow assays market size is expected to reach USD 13.60 billion by 2030, registering a CAGR of 4.26% over the forecast period, according to a new report by Grand View Research, Inc. Major factors driving the growth include the rising prevalence of infectious diseases, growing government initiatives to curb infectious and chronic diseases, rise in demand for point-of-care testing, and increasing strategic mergers & acquisitions among others.   Lateral flow assays were developed about half a century ago and have facilitated several diagnostic and testing applications in domains such as healthcare, food & beverage testing, and environmental testing. Similarly, lateral flow assay applications in point-of-care diagnostics are growing and are propelling significant advancements in research for the development of products that evaluate body fluids, such as urine and saliva. The use of these devices promo...

  Lateral Flow Assays Industry Overview The global lateral flow assays market size was valued at USD 7.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.0% from 2021 to 2028. Lateral Flow Assays (LFAs) have been developed over half a century ago, facilitating diagnosis across several applications, such as healthcare, environmental testing, and food and beverage. The use of LFAs in point of care diagnostic settings has been gaining significant traction in the research community in turn, driving the growth of the market for lateral flow assays. The use of POC devices reduces the need for laboratory testing eliminating the need for trained laboratory personnel and propelling self-testing. Although several technological advancements have been made in the recent past, several emerging economies are still facing the struggle to get timely medical intervention in times of need. This is one of the major factors propelling market growth as dipsticks...